HomeCompany overviewLeadership teamStrategy Advisory BoardPartners & InstitutionsTherapeutic AreasTherapeutic ApproachInnovative Lipid VectorsPipelineGAO-3-02 / GAO-11-02NewsContact
Back to posts index


GAOMA Therapeutics will attend the 16th EILAT Conference on New Antiepileptic Drugs and Devices on May 22-25, 2022, in Madrid, Spain.

Monday afternoon, Selena BODENNEC, CSO and co-founder of GAOMA, will be giving a lecture on GAO-3-02.

The EILATConference is an international event of reference, providing every 2 years an in-depth progress report on new antiepileptic drugs in various stages of development, as well as new findings on second-generation treatments.

Our team members will be pleased to meet with you and discuss the progress of our drug candidate GAO-3-02, which was first presented at EILAT XV in 2020.